| Issue Date | Title | Author(s) |
| Sep-2016 | A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions | Darbà, Josep; Ramírez, Gabriela; García-Rivero, Juan L.; Mayoralas, Sagrario; Pascual, José Francisco; Roger, Albert; Vargas, Diego; Bijedic, Adi |
| Jan-2021 | A discrete choice experiment to understand preferences of patients with type 2 diabetes treated with injectable non-insulinic agents | Darbà, Josep; Ascanio, Meritxell |
| Apr-2019 | Admissions and Cost of Hospitalisation of Phenylketonuria: Spanish Claims Database Analysis | Darbà, Josep; Ascanio, Meritxell |
| 26-May-2022 | Ambulatory and hospital care of glaucoma in Spain and associated medical costs | Darbà, Josep; Marsà, Alícia |
| 4-May-2021 | Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018) | Darbà, Josep; Marsà, Alícia |
| 13-Feb-2020 | Analysis of the management and costs of headache disorders in Spain during the period 2011-2016: a retrospective multicentre observational study | Darbà, Josep; Marsà, Alícia |
| Jul-2021 | Atopic dermatitis in specialized centers in Spain: a retrospective analysis of incidence and costs (2000-2017) | Darbà, Josep; Marsà, Alícia |
| Sep-2018 | Budget impact analysis of oral Fisiogen Ferro Forte versus intravenous iron for the management of iron deficiency in chronic kidney disease in Spain | Darbà, Josep; Ascanio, Meritxell |
| Jan-2021 | Burden of Hodgkin and non-Hodgkin lymphoma in Spain over a 10-year period: productivity losses due to premature mortality | Darbà, Josep; Marsà, Alícia |
| 1-Oct-2022 | Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care | Darbà, Josep; Marsà, Alícia |
| Oct-2019 | Characteristics, comorbidities, and use of healthcare resources of patients with phenylketonuria: a population-based study | Darbà, Josep |
| 5-Feb-2020 | Characteristics, management and medical costs of patients with depressive disorders admitted in primary and specialised care centres in Spain between 2011 and 2016 | Darbà, Josep; Marsà, Alícia |
| 28-Oct-2021 | Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs | Darbà, Josep; Marsà, Alícia |
| Dec-2020 | Chronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011-2017) | Darbà, Josep; Marsà, Alícia |
| Feb-2019 | Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin | Sicras Mainar, Antoni; Rejas, Javier; Pérez-Paramo, Maria; Sánchez-Álvarez, Luis; Navarro-Artieda, Ruth; Darbà, Josep |
| Nov-2017 | Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus - from the Spanish National Health System perspective | Mezquita-Raya, Pedro; Darbà, Josep; Ascanio, Meritxell; Ramírez de Arellano, Antonio |
| 20-Dec-2019 | Cost-effectiveness of insulin degludec versus insulin glargine U100 in patients with type 1 and type 2 diabetes in Portugal: evidence from SWITCH 1&2 trials | Darbà, Josep; Ascanio, Meritxell; Carvalho, Davide; Conde, Vasco; Pedersen, Kasper S. |
| Feb-2015 | Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain | Darbà, Josep; Kaskens, Lisette; Sorio Vilela, Francesc; Lothgren, Mickael |
| 11-Oct-2019 | Current status and direct medical cost of amyotrophic lateral sclerosis in the region of Catalonia: A population-based analysis | Darbà, Josep |
| Apr-2020 | Current status and use of resources of Lysosomal Storage Diseases: Analysis of a Spanish claims database | Darbà, Josep; Marsà, Alícia |
| Jul-2020 | Current status of lung cancer in Spain: a retrospective analysis of patient characteristics, use of healthcare resources and in-hospital mortality | Darbà, Josep; Marsà, Alícia |
| 1-Mar-2022 | Direct medical costs of non-alcoholic fatty liver disease in Catalonia at the hospital level: a retrospective multicenter study | Darbà, Josep |
| Apr-2020 | Direct Medical Costs of Spinal Muscular Atrophy in the Catalonia Region: A Population-Based Analysis | Darbà, Josep |
| Mar-2015 | Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study | Darbà, Josep; Kaskens, Lisette; Detournay, Bruno; Kern, Werner; Nicolucci, Antonio; Orozco-Beltrán, Domingo; Ramírez de Arellano, Antonio |
| Apr-2015 | Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study | Darbà, Josep; Kaskens, Lisette; Pérez Álvarez, Núria; Palacios Ruiz, Lucas Santiago; Neyro, José Luis; Rejas, Javier |
| Jul-2021 | Disease burden on health care by pain severity and usual analgesic treatment in patients with symptomatic osteoarthritis: a Spanish nationwide health survey | Rejas, Javier; Llopart, Natàlia; García-López, Sofia; Darbà, Josep |
| 11-Dec-2020 | Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain | Romero Gómez, Manuel 1967-; Kachru, Nandita; Ascanio, Meritxell; Darbà, Josep; Shreay, Sanatan |
| 23-Apr-2021 | Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden | Darbà, Josep; Ascanio, Meritxell; Syk, Jörgen; Alving, Kjell |
| 1-Mar-2021 | Economic impact of dry eye disease in Spain: A multicentre retrospective insurance claims database analysis | Darbà, Josep; Ascanio, Meritxell |
| 1-Dec-2022 | Economic Implications of Endometriosis: A Review | Darbà, Josep; Marsà, Alícia |
| Mar-2019 | Enzymatic replacement therapy for lysosomal storage disorders: Drug evaluations review in Spain | Darbà, Josep; Ascanio, Meritxell |
| 10-Mar-2020 | Epidemiology and management of parathyroid gland disorders in Spain over 15 years: A retrospective multicentre analysis | Darbà, Josep; Marsà, Alícia |
| Jul-2020 | Epidemiology, management and costs of sepsis in Spain (2008-2017): a retrospective multicentre study | Darbà, Josep; Marsà, Alícia |
| Dec-2020 | Epidemiology, management, and economic impact of acute myeloid leukemia and myelodysplastic syndrome in Spain: a claims database analysis | Marsà, Alícia; Ascanio, Meritxell; Diaz-García, Javier; Darbà, Josep |
| Nov-2022 | Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model | Eleftheriou, Androulla; Antoniou, Eleni; Darbà, Josep; Ascanio, Meritxell; Angastiniotis, Michael; Farmakis, Dimitrios |
| Feb-2017 | Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax compared with Turbuhaler in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain | Darbà, Josep; Ramírez, Gabriela; García-Rivero, Juan L.; Mayoralas, Sagrario; Pascual, José Francisco; Vargas, Diego; Bijedic, Adi |
| 23-Dec-2020 | Evaluation of productivity losses due to premature mortality from colorectal cancer | Darbà, Josep; Marsà, Alícia |
| Dec-2019 | Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources | Darbà, Josep; Marsà, Alícia |
| 1-Mar-2022 | Hospital care and medical costs of septic arthritis in Spain: a retrospective multicenter analysis | Darbà, Josep; Marsà, Alícia |
| 1-May-2022 | Hospital care of endometriosis in Spain: a retrospective multicenter analysis of patient characteristics and costs | Darbà, Josep; Marsà, Alícia |
| 1-Aug-2022 | Hospital incidence and costs of congenital hydrocephalus in Spain: a multicenter retrospective study | Darbà, Josep; Marsà, Alícia |
| 1-Nov-2022 | Hospital Incidence and Medical Costs of Female Breast Cancer in Spain: A Retrospective Multicenter Study | Darbà, Josep; Marsà, Alícia |
| Oct-2022 | Hospital incidence and medical costs of polycythemia vera in Spain: a retrospective database analysis | Darbà, Josep; Marsà, Alícia |
| 1-Mar-2021 | Hospital incidence, in-hospital mortality and medical costs of pneumococcal disease in Spain (2008-2017): a retrospective multicentre study | Darbà, Josep; Marsà, Alícia |
| Dec-2020 | Hospital incidence, management and direct cost of osteogenesis imperfecta in Spain: a retrospective database analysis | Darbà, Josep; Marsà, Alícia |
| Sep-2021 | Hospital incidence, mortality and costs of Alzheimer's disease in Spain: a retrospective multicenter study | Darbà, Josep; Marsà, Alícia |
| 7-Apr-2021 | Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain | Olry de Labry Lima, Antonio; Díaz Castro, Óscar; Romero Requena, Jorge M.; García Díaz-Guerra, M. Reyes; Arroyo Pineda, Virginia; Hija Díaz, Belén de la; Ascanio, Meritxell; Darbà, Josep; Cruzado, Josep M. |
| 9-Feb-2016 | Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance | Darbà, Josep; Ramírez, Gabriela; Sicras Mainar, Antoni; García-Bujalance, Laura; Torvinen, Saku; Sánchez de la Rosa, Rainel |
| 27-Feb-2023 | Incidence and medical costs of chronic obstructive respiratory disease in Spanish hospitals: a retrospective database analysis | Darbà, Josep; Ascanio, Meritxell |
| 1-May-2021 | Incidence, mortality and medical costs of patients hospitalized with melanoma in Spain: a retrospective multicentre observational study | Darbà, Josep; Marsà, Alícia |
| 10-Jan-2020 | Management and current status of spinal muscular atrophy: a retrospective multicentre claims database analysis. | Darbà, Josep |
| 1-Nov-2019 | Patient characteristics and hospitalisation costs of spinal muscular atrophy in Spain: a retrospective multicentre database analysis | Darbà, Josep; Marsà, Alícia |
| 2015 | Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain | Darbà, Josep; Kaskens, Lisette |
| 10-Feb-2020 | Results after 10 years of colorectal cancer screenings in Spain: Hospital incidence and inhospital mortality (2011-2016) | Darbà, Josep; Marsà, Alícia |
| 23-Oct-2019 | The cost of lost productivity due to premature lung cancer-related mortality: results from Spain over a 10-year period | Darbà, Josep; Marsà, Alícia |
| Oct-2019 | The current performance-linked and risk sharing agreement scene in the Spanish region of Catalonia | Darbà, Josep; Ascanio, Meritxell |
| 2015 | The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients | Darbà, Josep; Ramírez, Gabriela; Sicras Mainar, Antoni; Francoli, Pablo; Torvinen, Saku; Sánchez de la Rosa, Rainel |
| 2019 | Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain | Darbà, Josep; Ascanio, Meritxell |
| Dec-2018 | Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis | Sicras Mainar, Antoni; Sánchez-Álvarez, Luis; Navarro-Artieda, Ruth; Darbà, Josep |
